This suggests that the high myelination efficiency observed in IVMDE could generate new indexes for evaluating myelination allowing discovery of therapeutic interventions that normalize the myelin profile length and MBP intensity as seen in many peripheral nerve diseases causing dysmyelination. This evidence concerns the gene MBP and peripheral nervous system disorder.